C23-32992-52293
5 vaccinations
13 coded responses
33 check-ins
13 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 112 / NY
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Registered in v-safe
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-13
- 2021-01-19
-
2021-01-26
Dose 2 — Pfizer-BioNTech
- 2021-01-27
- 2021-01-28
- 2021-01-29
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Mobility decreased — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Laying in bed a lot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia — Feeling: Good · Fatigue or tirednessFree text: Low energy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-10
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-28
- 2021-07-27
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2022-01-26
-
2022-07-18
Dose 4 — Pfizer-BioNTech
-
2022-10-01
Dose 5 — Pfizer-BioNTech
-
2022-10-03
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: GoodFree text: No.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: GoodFree text: No noticeable symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Survey response — day 7, dose 5MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Survey response — day 14, dose 5MedDRA: Productive cough, Respiratory tract congestion, Sneezing, Sputum discoloured, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, sneezing,, coughing up brown slime, cloudy vision.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Survey response — day 21, dose 5MedDRA: Headache, Lethargy, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cloudy vision, lethargy, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Survey response — day 28, dose 5MedDRA: Depression, Listless — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Listlessness, depression.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Survey response — day 35, dose 5MedDRA: Fatigue, Feeling of despair, Irritability — Feeling: Poor · Be unable to work or attend schoolFree text: Lassitude, despair, irritabilityMedDRA releases: 2024-11 · check-in free text available
- 2022-11-12
-
2022-12-31
Survey response — 3 months, dose 5MedDRA: Asthenia, Back pain, Depressed mood, Rhinorrhoea, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Now taking antibiotics, nasal spray, and eye drops to combat excessive nasal discharge that decreases the quality of my vision. Also, back pain that might be due to lying abed the greater part of the day. I have little energy and feel dispirited.MedDRA releases: 2024-11 · check-in free text available
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-07-18 | Pfizer-BioNTech | No |
| 5 | 2022-10-01 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Laying in bed a lot.
Systemic reaction (other): Low energy.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): No.
Systemic reaction (other): No noticeable symptoms.
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 12 — day 7, dose 5
Systemic reaction (other): No
Release 12 — day 14, dose 5
Symptoms: Congestion, sneezing,, coughing up brown slime, cloudy vision.
Release 12 — day 21, dose 5
Symptoms: Cloudy vision, lethargy, headache
Release 12 — day 28, dose 5
Symptoms: Listlessness, depression.
Release 12 — day 35, dose 5
Symptoms: Lassitude, despair, irritability
Release 12 — 3 months, dose 5
Symptoms: Now taking antibiotics, nasal spray, and eye drops to combat excessive nasal discharge that decreases the quality of my vision. Also, back pain that might be due to lying abed the greater part of the day. I have little energy and feel dispirited.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Depressed mood | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling of despair | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Listless | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Mobility decreased | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release